Last reviewed · How we verify
NCT05044000
Effect of Deep Propioceptive Stimulation in Prader-Willi Syndrome
NA trial testing Deep propioceptive stimulation in Sleep Disorder in 60 participants. Completed in 10 December 2024.
10 March 2024
Quick facts
| Lead sponsor | Corporacion Parc Tauli |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 10 February 2022 |
| Primary completion | 10 March 2024 |
| Estimated completion | 10 December 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Deep propioceptive stimulation
Conditions studied
- Sleep Disorder — all drugs for Sleep Disorder →
- Hyperphagia — all drugs for Hyperphagia →
- Behavior Disorders — all drugs for Behavior Disorders →
Sponsor
Corporacion Parc Tauli — full company profile →
Who can join
16 and older, any sex, with Sleep Disorder or Hyperphagia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective is to study the effect of deep propioceptive stimulation with a heavy blanket for 2 weeks compared with a placebo blanket on sleep quality and behavior in patients with PWS
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05044000
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sleep Disorder
Currently open trials in the same condition.
- NCT07485790 — The Effects of Yoga on Pregnant Women · NA · recruiting
- NCT06990256 — Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers · NA · recruiting
- NCT04949360 — SleepUp Digital CBTi-based Platform for Insomnia · NA · recruiting
- NCT05649514 — Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease · NA · recruiting
- NCT06914466 — Neural Mechanisms and Clinical Applications of DBS for Modulating Sleep Dysregulation in PD · recruiting
Other Corporacion Parc Tauli trials
Trials by the same sponsor.
- NCT07331805 — Conservative Management in Primary Spontaneous Pneumothorax: a Multicenter Randomized Non-inferiority Study · NA · not yet recruiting
- NCT06873360 — Medical Device for Oxaliplatin-Induced Neuropathy in Gastrointestinal Cancer Patients · completed
- NCT06900335 — Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact · completed
- NCT06511700 — Implementation of the Intravitreal Injection Administered by Nurses · enrolling by invitation
- NCT07298720 — Assessing Fluid-responsiveness Using Non-invasive Hybrid Diffuse Optics on Peripheral Muscle · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05044000 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Corporacion Parc Tauli
- Last refreshed: 25 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05044000.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing